Developer docs
API playgroundTry for free, no card

Search company profiles

Evio

Full company profile

uuid000tyvu

Namestring
Evio
Legal namestring
EVIO Inc.
Websiteurl
eviolabs.com
Company typeenum
Public
Founded yearint
2014
Descriptiontext

EVIO Inc. (OTC: EVIO) is a publicly traded provider of ISO 17025 accredited analytical testing and advisory services for the cannabis, hemp, and CBD industries, headquartered in Henderson, Nevada. Founded in 2014 (originally as Signal Bay), the company operates a network of licensed laboratories across North America, with current operations in Oregon (Portland and Medford), California (Berkeley, operating as Steep Hill California via C3 Labs LLC), and Canada (Edmonton, via a 50%-owned Keystone Labs subsidiary). EVIO's core offering is state-mandated compliance testing for regulated cannabis products — potency (up to 13 cannabinoids), terpenes (42), pesticides (66), heavy metals, residual solvents, microbial contaminants, moisture, and mycotoxins — alongside an expanding portfolio of differentiated services including Next Generation Sequencing (NGSS) genomic pathogen detection, DNA-based plant sex determination, Vitamin E Acetate screening (added post-EVALI), and the Hemp & CBD Safety Panel.

Underlying technology is rooted in conventional analytical chemistry (UHPLC chromatography, mass spectrometry) and molecular biology (DNA sequencing, metagenomic assembly), not proprietary AI/ML systems. The company monetizes through per-test, quote-based pricing for compliance panels and a premium same-day potency testing tier, distributed via direct B2B sales teams at lab locations and the national self-serve hemptesting.com platform launched after the 2018 Farm Bill. In 2021, EVIO filed Form 15 to suspend SEC reporting obligations and pivoted strategically toward blockchain-based product authentication (Chroma Signet partnership) and cryptocurrency mining as balance sheet diversification, while discontinuing operations in several previously entered geographies.

Short descriptiontext

EVIO Inc. (OTC: EVIO) operates an ISO 17025 accredited network of analytical testing laboratories serving licensed cannabis, hemp, and CBD producers across Oregon, California, and Canada with compliance and advisory testing services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHenderson, United States
HQ citystring
Henderson
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis testing services, hemp product testing, analytical laboratory services, CBD compliance testing, ISO 17025 accredited
Industry2 codes
1Food Testing Laboratories (Microbiological, Chemical, Allergen)
CodeAFALAAAAPrimaryYes
2Residue & Contaminant Testing (Pesticides, Vet Drugs, Mycotoxins, Heavy Metals)
CodeAFALAAAFPrimaryNo
NAICS code1 code
  • Testing Laboratories and Services541380
SIC code1 code
  • Services-Testing Laboratories8734
Product category
Cannabis and Hemp Analytical Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Cannabis Compliance Testing
TypeProfessional Services
Description

State-mandated analytical testing services for regulated cannabis products. Revenue is generated on a per-test basis for flower, trim, manufactured products, biomass, crude oils, isolates, distillates, edibles, patches, and aerosols. Tests include potency, pesticides, heavy metals, residual solvents, microbial, and terpenes. Services include same-day potency testing at a premium fee and standard three-day full compliance testing.

eviolabs.com
2Hemp and CBD Product Testing
TypeProfessional Services
Description

ISO 17025 accredited testing for hemp and hemp-derived CBD products nationwide through hemptesting.com. Includes the Hemp and CBD Safety Panel, compliance testing for federal and state requirements, and USDA-required DEA-certified laboratory testing. Revenue from testing fees per sample.

eviolabs.com
3Consulting & Advisory Services
TypeProfessional Services
Description

Quality analytical R&D and consulting services to help clients produce compliant products. Includes business intelligence consulting for cannabis startups, regulatory compliance guidance, and government agency consulting.

eviolabs.com
4Blockchain Verification Services
TypeProfessional Services
Description

Diversification into blockchain space through partnership with Chroma Signet to offer blockchain verification services for cannabis, hemp, and CBD products, including NFT-based product authentication and namespace verification throughout the supply chain.

eviolabs.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components1 value
Personnel
Pricing details3 tiers
1Same-Day Potency Testing (Premium)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Same-day potency testing available at a premium fee for clients requiring expedited results.

eviolabs.com
2Standard Compliance Testing (3-Day)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Three-day full compliance testing at standard rate.

eviolabs.com
3Hemp and CBD Testing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Reliable results in approximately one week; pricing not publicly disclosed.

eviolabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

EVIO Labs operates a network of ISO 17025 accredited analytical laboratories providing state-mandated compliance testing for cannabis products and hemp/CBD product testing across Oregon, California, and Canada. The company offers a broad test panel covering potency (up to 13 cannabinoids), 42 terpenes, 66 pesticides, heavy metals, residual solvents, microbial contaminants, mycotoxins, and DNA-based plant sex determination. EVIO also provides consulting/advisory services and blockchain-based product authentication through a partnership with Chroma Signet.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Revenue increased 84% in Q3 2019 vs Q3 2018
+4 more records
Product overview1 text field

EVIO Labs operates as a network of ISO 17025 accredited testing laboratories providing comprehensive analytical testing and advisory services for the cannabis, hemp, and CBD industry. The core offering is EVIO Labs, supplemented by the HempTesting.com national ordering platform and regional sub-brands including EVIO Labs Canada (Keystone Labs). Testing services span a broad portfolio including potency testing (up to 13 cannabinoids), pesticide testing (66 pesticides), residual solvents, heavy metals, microbial tests, 42 terpenes, moisture content, and specialized services such as immature plant inspections, genomic pathogens testing via Next Generation Sequencing, mycotoxins screening, and Vitamin E Acetate testing. The company also offers blockchain-based product authentication through a partnership with Chroma Signet, enabling supply chain transparency and counterfeit prevention.

Product and service1 record
1Cannabis Compliance Testing Services
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-11-24
Description

EVIO partnered with Chroma Signet to offer blockchain verification services for cannabis, hemp, CBD and related products. Chroma Signet's platform enables product authentication through cryptographic signatures attached to cannabis products throughout the supply chain. EVIO provides verification services and assists customers in joining Chroma Signet's Decentralized Autonomous Organization (DAO), which acquires a special NFT namespace for origin verification. This partnership addresses product authentication challenges including improper genetic tracing, arbitrary strain name assignments, and counterfeit test results.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-12-02
Description

Subject to Massachusetts Cannabis Control Commission (CCC) approval, EVIO planned to form a partnership with Green Analytics MA. Green Analytics would acquire 49% of Viridis Analytics LLC, be responsible for day-to-day operations, and operate as Steep Hill MA. Green Analytics already operates several successful laboratories along the eastern seaboard including Pennsylvania and Maryland. This partnership helps EVIO resume testing operations in Massachusetts.

Strategic tierCoreTypeOthersAnnounced on2017-01-01
Description

EVIO acquired a 50% share of Keystone Labs in Edmonton, Alberta, Canada. Keystone Labs is a fully operational licensed cannabis testing lab that completed installation of heavy metal testing capability and can now perform all Health Canada mandated tests required for cannabis. Recognized as Top Testing Lab in 2019 Canadian Cannabis Awards.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the earliest cannabis testing laboratories in the U.S., offering cannabinoid, terpene, pesticide, and contaminant panels. EVIO actually operates C3 Labs LLC d/b/a Steep Hill Labs CA in Berkeley, making this its most direct comparison and closest operating peer.

TypeBroad incumbent
Description

Global analytical testing leader with broad food, environmental, and pharmaceutical testing capabilities. Eurofins could enter or already serves adjacent cannabis testing niches, representing the eventual scaled incumbent that multi-state operators like EVIO face as legalization matures.

TypeDirect peer
Description

California-based cannabis testing lab offering full compliance panels (potency, terpenes, pesticides, heavy metals, residual solvents, microbials), serving cultivators, manufacturers, and distributors in California's regulated market.

TypeEmerging player
Description

Cannabis genetics and genomics company using DNA sequencing for plant sex determination, pathogen detection, and genetic certification. Overlaps with EVIO's NGS and DNA-based testing services and competes for hemp and cannabis breeder customers.

TypeDirect peer
Description

Florida-based cannabis testing lab with national reach, offering ISO 17025-accredited potency, contaminant, and terpene testing - comparable to EVIO in scope and accreditation profile.

TypeDirect peer
Description

Massachusetts-licensed cannabis testing lab serving cultivators and dispensaries in the Northeast U.S., offering compliance and R&D testing - directly comparable to EVIO's planned Massachusetts operations.

TypeDirect peer
Description

Long-standing analytical testing laboratory providing cannabis compliance and contaminant testing for the California market, with deep experience in pesticide, mycotoxin, and microbial testing - directly comparable to EVIO's California lab.

TypeDirect peer
Description

Cannabis testing lab serving California and other Western U.S. states with ISO 17025-accredited potency, contaminant, and terpene testing - a direct competitor for licensed cannabis compliance work in EVIO's core California market.

TypeDirect peer
Description

Oregon-based cannabis testing laboratory providing ISO 17025-accredited compliance testing services for the Oregon recreational and medical markets - one of EVIO's key Oregon market competitors.

TypeBroad incumbent
Description

One of the world's largest testing, inspection, and certification companies with broad agricultural and food testing services. As cannabis testing becomes mainstream, SGS represents the diversified global incumbent likely to compete for large multi-state testing contracts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Evio

Cannabis and Hemp Analytical Testing Serviceseviolabs.com

EVIO Inc. (OTC: EVIO) operates an ISO 17025 accredited network of analytical testing laboratories serving licensed cannabis, hemp, and CBD producers across Oregon, California, and Canada with compliance and advisory testing services.

What Evio does

EVIO Inc. (OTC: EVIO) is a publicly traded provider of ISO 17025 accredited analytical testing and advisory services for the cannabis, hemp, and CBD industries, headquartered in Henderson, Nevada. Founded in 2014 (originally as Signal Bay), the company operates a network of licensed laboratories across North America, with current operations in Oregon (Portland and Medford), California (Berkeley, operating as Steep Hill California via C3 Labs LLC), and Canada (Edmonton, via a 50%-owned Keystone Labs subsidiary). EVIO's core offering is state-mandated compliance testing for regulated cannabis products — potency (up to 13 cannabinoids), terpenes (42), pesticides (66), heavy metals, residual solvents, microbial contaminants, moisture, and mycotoxins — alongside an expanding portfolio of differentiated services including Next Generation Sequencing (NGSS) genomic pathogen detection, DNA-based plant sex determination, Vitamin E Acetate screening (added post-EVALI), and the Hemp & CBD Safety Panel.

Underlying technology is rooted in conventional analytical chemistry (UHPLC chromatography, mass spectrometry) and molecular biology (DNA sequencing, metagenomic assembly), not proprietary AI/ML systems. The company monetizes through per-test, quote-based pricing for compliance panels and a premium same-day potency testing tier, distributed via direct B2B sales teams at lab locations and the national self-serve hemptesting.com platform launched after the 2018 Farm Bill. In 2021, EVIO filed Form 15 to suspend SEC reporting obligations and pivoted strategically toward blockchain-based product authentication (Chroma Signet partnership) and cryptocurrency mining as balance sheet diversification, while discontinuing operations in several previously entered geographies.

Evio firmographics

Firmographics
Name
Evio
Legal name
EVIO Inc.
Website
https://eviolabs.com
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
EVIO Inc. (OTC: EVIO) operates an ISO 17025 accredited network of analytical testing laboratories serving licensed cannabis, hemp, and CBD producers across Oregon, California, and Canada with compliance and advisory testing services.
Ownership category
akta.pro rank

Evio industry classification

Industry
Product category
Cannabis and Hemp Analytical Testing Services
NAICS
Testing Laboratories and Services (541380)
SIC
Services-Testing Laboratories (8734)
akta.pro primary industry
Food Testing Laboratories (Microbiological, Chemical, Allergen) (AFALAAAA)
akta.pro secondary industry
Residue & Contaminant Testing (Pesticides, Vet Drugs, Mycotoxins, Heavy Metals) (AFALAAAF)

Keywords

  • Cannabis testing services
  • Hemp product testing
  • Analytical laboratory services
  • CBD compliance testing
  • ISO 17025 accredited

Where Evio is headquartered

Location

Headquarters

HQ city
Henderson
HQ country
United States
HQ region
North America

Offices7 records

Markets served

Evio business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel

Revenue model

  1. Cannabis Compliance Testing: State-mandated analytical testing services for regulated cannabis products. Revenue is generated on a per-test basis for flower, trim, manufactured products, biomass, crude oils, isolates, distillates, edibles, patches, and aerosols. Tests include potency, pesticides, heavy metals, residual solvents, microbial, and terpenes. Services include same-day potency testing at a premium fee and standard three-day full compliance testing.
  2. Hemp and CBD Product Testing: ISO 17025 accredited testing for hemp and hemp-derived CBD products nationwide through hemptesting.com. Includes the Hemp and CBD Safety Panel, compliance testing for federal and state requirements, and USDA-required DEA-certified laboratory testing. Revenue from testing fees per sample.
  3. Consulting & Advisory Services: Quality analytical R&D and consulting services to help clients produce compliant products. Includes business intelligence consulting for cannabis startups, regulatory compliance guidance, and government agency consulting.
  4. Blockchain Verification Services: Diversification into blockchain space through partnership with Chroma Signet to offer blockchain verification services for cannabis, hemp, and CBD products, including NFT-based product authentication and namespace verification throughout the supply chain.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSame-Day Potency Testing (Premium)
Unit PricingPay-as-you-goStandard Compliance Testing (3-Day)
Unit PricingPay-as-you-goHemp and CBD Testing

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Evio product offering

Product offering

Core offering

EVIO Labs operates a network of ISO 17025 accredited analytical laboratories providing state-mandated compliance testing for cannabis products and hemp/CBD product testing across Oregon, California, and Canada. The company offers a broad test panel covering potency (up to 13 cannabinoids), 42 terpenes, 66 pesticides, heavy metals, residual solvents, microbial contaminants, mycotoxins, and DNA-based plant sex determination. EVIO also provides consulting/advisory services and blockchain-based product authentication through a partnership with Chroma Signet.

Product overview

EVIO Labs operates as a network of ISO 17025 accredited testing laboratories providing comprehensive analytical testing and advisory services for the cannabis, hemp, and CBD industry. The core offering is EVIO Labs, supplemented by the HempTesting.com national ordering platform and regional sub-brands including EVIO Labs Canada (Keystone Labs). Testing services span a broad portfolio including potency testing (up to 13 cannabinoids), pesticide testing (66 pesticides), residual solvents, heavy metals, microbial tests, 42 terpenes, moisture content, and specialized services such as immature plant inspections, genomic pathogens testing via Next Generation Sequencing, mycotoxins screening, and Vitamin E Acetate testing. The company also offers blockchain-based product authentication through a partnership with Chroma Signet, enabling supply chain transparency and counterfeit prevention.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cannabis Compliance Testing Services

Quantifiable outcome

  • Revenue increased 84% in Q3 2019 vs Q3 2018
  • +4 more outcomes

Companies that use Evio

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Evio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Evio partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Chroma SignetcoreTechnology or Integration · 24 November 2021EVIO partnered with Chroma Signet to offer blockchain verification services for cannabis, hemp, CBD and related products. Chroma Signet's platform enables product authentication through cryptographic signatures attached to cannabis products throughout the supply chain. EVIO provides verification services and assists customers in joining Chroma Signet's Decentralized Autonomous Organization (DAO), which acquires a special NFT namespace for origin verification. This partnership addresses product authentication challenges including improper genetic tracing, arbitrary strain name assignments, and counterfeit test results.
  • Green Analytics MAminorStrategic or Co-development Partner · 2 December 2019Subject to Massachusetts Cannabis Control Commission (CCC) approval, EVIO planned to form a partnership with Green Analytics MA. Green Analytics would acquire 49% of Viridis Analytics LLC, be responsible for day-to-day operations, and operate as Steep Hill MA. Green Analytics already operates several successful laboratories along the eastern seaboard including Pennsylvania and Maryland. This partnership helps EVIO resume testing operations in Massachusetts.
  • Keystone Labs (Edmonton, Alberta)coreOthers · 1 January 2017EVIO acquired a 50% share of Keystone Labs in Edmonton, Alberta, Canada. Keystone Labs is a fully operational licensed cannabis testing lab that completed installation of heavy metal testing capability and can now perform all Health Canada mandated tests required for cannabis. Recognized as Top Testing Lab in 2019 Canadian Cannabis Awards.

Scale indicators6 records

Recent moves9 records

Expansion highlights6 records

Evio competitors and assessment

Company assessment

Direct peers

  • Steep Hill Labs: One of the earliest cannabis testing laboratories in the U.S., offering cannabinoid, terpene, pesticide, and contaminant panels. EVIO actually operates C3 Labs LLC d/b/a Steep Hill Labs CA in Berkeley, making this its most direct comparison and closest operating peer.
  • CannaSafe Solutions: California-based cannabis testing lab offering full compliance panels (potency, terpenes, pesticides, heavy metals, residual solvents, microbials), serving cultivators, manufacturers, and distributors in California's regulated market.
  • ACS Laboratory: Florida-based cannabis testing lab with national reach, offering ISO 17025-accredited potency, contaminant, and terpene testing - comparable to EVIO in scope and accreditation profile.
  • MCR Labs: Massachusetts-licensed cannabis testing lab serving cultivators and dispensaries in the Northeast U.S., offering compliance and R&D testing - directly comparable to EVIO's planned Massachusetts operations.
  • Anresco Laboratories: Long-standing analytical testing laboratory providing cannabis compliance and contaminant testing for the California market, with deep experience in pesticide, mycotoxin, and microbial testing - directly comparable to EVIO's California lab.
  • SC Laboratories: Cannabis testing lab serving California and other Western U.S. states with ISO 17025-accredited potency, contaminant, and terpene testing - a direct competitor for licensed cannabis compliance work in EVIO's core California market.
  • Cascadia Labs: Oregon-based cannabis testing laboratory providing ISO 17025-accredited compliance testing services for the Oregon recreational and medical markets - one of EVIO's key Oregon market competitors.

Broad incumbents

  • Eurofins Scientific: Global analytical testing leader with broad food, environmental, and pharmaceutical testing capabilities. Eurofins could enter or already serves adjacent cannabis testing niches, representing the eventual scaled incumbent that multi-state operators like EVIO face as legalization matures.
  • SGS SA: One of the world's largest testing, inspection, and certification companies with broad agricultural and food testing services. As cannabis testing becomes mainstream, SGS represents the diversified global incumbent likely to compete for large multi-state testing contracts.

Emerging players

  • Phylos Bioscience: Cannabis genetics and genomics company using DNA sequencing for plant sex determination, pathogen detection, and genetic certification. Overlaps with EVIO's NGS and DNA-based testing services and competes for hemp and cannabis breeder customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Evio social profiles

Digital presence

Evio compliance and trust

Trust signal

Compliance3 records

Evio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Evio leadership team

Management profile

Number of profiles

Profiles6 records

Evio subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Evio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Evio M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evio

What does Evio do?

EVIO Labs operates a network of ISO 17025 accredited analytical laboratories providing state-mandated compliance testing for cannabis products and hemp/CBD product testing across Oregon, California, and Canada. The company offers a broad test panel covering potency (up to 13 cannabinoids), 42 terpenes, 66 pesticides, heavy metals, residual solvents, microbial contaminants, mycotoxins, and DNA-based plant sex determination. EVIO also provides consulting/advisory services and blockchain-based product authentication through a partnership with Chroma Signet.

Is Evio a public or private company?

Evio is a public company. It is classified as public and is currently operating.

When was Evio founded?

Evio was founded in 2014. It employs 11 to 50 people.

Where is Evio based?

Evio is headquartered in Henderson, United States, in the North America region.

How does Evio make money?

Four revenue lines are on record. Cannabis Compliance Testing is the primary driver. The others are hemp and CBD Product Testing, consulting & Advisory Services and blockchain Verification Services.

Who are Evio's main competitors?

Direct peers on record are Steep Hill Labs, CannaSafe Solutions, ACS Laboratory, MCR Labs, Anresco Laboratories, SC Laboratories and Cascadia Labs. Broad incumbents are Eurofins Scientific and SGS SA. Phylos Bioscience is listed as an emerging player.

Does Evio have an API?

No public API is recorded for Evio.

What industry is Evio in?

Evio's product category is Cannabis and Hemp Analytical Testing Services. Its primary akta.pro industry code is AFALAAAA, Food Testing Laboratories (Microbiological, Chemical, Allergen), with a secondary code of AFALAAAF, Residue & Contaminant Testing (Pesticides, Vet Drugs, Mycotoxins, Heavy Metals). Its NAICS code is 541380 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanEvio Inc Latest Stock News & Market UpdatesThe provided text is a navigational page for Evio Inc stock news rather than a single cohesive article, containing summaries of multiple unrelated corporate updates. It lists various historical events including debt restructuring, subsidiary expansions, and strategic partnerships without focusing on one specific recent development.ZoominfoEVIO - Overview, News & Similar companiesEVIO, Inc. announced a strategic partnership with Rare Earth Genomics Texas, LLC to test hemp products. The company also disclosed its intention to sell its ownership in Steep Hill CA to Digipath, Inc. in exchange for debt assumption and stock.PR NewswireEVIO Inc. Executes Letter of Intent to sell C3 Labs, LLC to Digipath, Inc.EVIO Inc. has executed a letter of intent to sell its ownership in C3 Labs, LLC (dba Steep Hill CA) to Digipath, Inc. in exchange for debt assumption and equity stock. This transaction is part of EVIO's restructuring strategy, aiming to divest over $2 million in debt while providing C3 Labs with necessary investment.PR NewswireEVIO, Inc. Announces Major Blockchain Partnership with Chroma SignetEVIO, Inc. announced a partnership with Chroma Signet to provide blockchain verification services for cannabis, hemp, and CBD products. The collaboration utilizes Chroma Signet's platform to help companies authenticate products and join a Decentralized Autonomous Organization (DAO) for tracking cryptographic signatures in the supply chain. This initiative aims to address industry challenges regarding product authentication and counterfeit test results.BioSpaceEVIO, Inc. provides Shareholder UpdateEVIO, Inc. reported a 5% decline in 2020 revenues to $3.6 million but achieved improved gross margins through lab consolidation and significant reductions in operating costs. The company mutually terminated a letter of intent to merge with Leading Edge Pharms due to regulatory conflicts of interest regarding CBD product testing. EVIO is now expanding its services to include safety testing for psychedelic substances in Canada and Oregon.PR NewswireEVIO, Inc. Files Form 15 to Suspend SEC Reporting Requirements and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet CompaniesEVIO, Inc. filed Form 15 with the SEC to terminate its registration under Section 12(g) of the Securities Exchange Act and suspend its SEC reporting obligations, including Forms 10-K, 10-Q, and 8-K. The company cited high audit costs and lengthy delays as the primary drivers for transitioning from Exchange Act reporting to OTC Markets Pink Sheets. EVIO will continue trading on OTC Pink Sheets and will disclose financial statements quarterly and annually through the OTC Markets Alternative Reporting Standard.Business Wire BlogEVIO Inc. Engages Experienced Cannabis Operator as Strategic AdvisorEVIO Inc. has retained Chris Boudreau as a strategic consultant to reposition the company, aiming to boost marketing, increase sales, and improve margins. Boudreau is tasked with leveraging his industry connections to develop and implement a new strategic plan intended to drive growth in 2021 and beyond.GlobeNewswireHempAmericana Readies Launch of Online Payment Processing System Following Positive CBD Lab ResultsHempAmericana will launch its online payment processing system after positive CBD product testing by EVIO Labs. All seven full-spectrum CBD formulas tested met legal limits, removing barriers to online sales. The company expects to monetize its inventory and pursue aggressive distribution in 2020.GlobeNewswireHempAmericana Announces Range of CBD Samples Sent to EVIO Labs for Certification of Highest Quality StandardsHempAmericana is sending seven full-spectrum CBD product formulas to EVIO Labs for testing, with samples ranging from 125mg to 2500mg. The company will receive Certificates of Analysis for each sample, which will be posted on its website. CEO Salvador Rosillo emphasized the commitment to high quality standards.Financial PostEVIO Canada's Keystone Labs Prospers in Ever Growing Cannabis Legalization MarketEVIO Inc. announced that its Canadian subsidiary, EVIO Canada’s Keystone Labs, is expanding operations and upgrading equipment to meet the testing demands of Canada's newly legalized cannabis market. The expansion aims to increase daily testing capacity from 20 to 40 samples by the end of 2019 to comply with Health Canada's stricter pesticide regulations. This move positions the company to capitalize on forecasted strong sales growth in the Canadian sector.